Aurora Pharmaceutical is pleased to announce the availability of EquiCoxib, the FDA-approved generic equivalent of Equioxx® ...

Q2 2025 Earnings Call Transcript February 12, 2025 ReposiTrak, Inc. misses on earnings expectations. Reported EPS is $0.08 EPS, expectations were $0.09. Operator: Greetings, and welcome to the ...

Welcome to the Q4 2024 Datadog earnings conference call. At this time, all participants are in a listen-only mode. After the ...

Operator Good morning, and welcome to Deere & Company first-quarter earnings conference call. [Operator instructions] I would ...

With looks that could kill, the Keychron Q12 Max is a force to be reckoned with. The hot-swappable and remappable board comes ...

Announced Proposed Transaction to Increase Tangible Book Value to Ben Public Company Stockholders by $9 Million on 8.4 Million Shares ...

Emily Fontaine, Global Head of Venture Capital, IBM; Jay Love, US Chief Investment Strategist, Mercer; and Alan McKnight, Chief Investment Officer, Regions Bank join Bloomberg Intelligence's ...

Industry-leading total Mobile and Fixed customer growth of 328,000 in the fourth quarter, driven by strong demand for our leading portfolio of bundled services across ...

Company delivers “Rule of 50” Performance in 2024 with 25% ARR growth and 25% adjusted EBITDA marginFourth-quarter 2024 revenue of $109.0 million ...

KALMAR CORPORATION, FINANCIAL STATEMENTS REVIEW 2024, 13 FEBRUARY 2025 AT 9:00 AM (EET) Kalmar's financial statements review January-December 2024: Resilient profitability and strong orders in the ...

For the past few years, mortgage brokers have been presented with a seemingly non-stop barrage of new mortgage technology.